Profound Medical Corp. (PROF) Balance Sheet

NASDAQ: PROFAssets, liabilities, debt and equity over 10 years.

PROF balance sheet, 2025

December 31, 2025 · U.S. dollars

$192.9M assets = $102.0M liabilities + $91.0M equity

What it owns$192.9MCash & ST investments: $81.8M (42.4%)Cash & ST investments$81.8M · 42%Receivables: $9.9M (5.1%)Inventory: $11.3M (5.8%)Inventory $11.3MOther current: $1.3M (0.7%)PP&E: $225,000 (0.1%)Goodwill & intangibles: $138,000 (0.1%)Other non-current: $88.4M (45.8%)Other non-current$88.4M · 46%=How it is financed$192.9MCurrent liabilities: $8.3M (4.3%)Long-term debt: $4.5M (2.3%)Other LT liabilities: $89.1M (46.2%)Other LT liabilities$89.1M · 46%Shareholders’ equity: $91.0M (47.2%)Shareholders’ equity$91.0M · 47%

Both columns are drawn to the same scale: what PROF owns equals what it owes plus shareholders’ equity. Hover a block for its value.

PROF financial health

Debt / equity0.07
Low leverage · $0.07 of debt for each $1 of equity
Equity / assets47.2%
Equity-funded · of assets funded by shareholders
Cash / debt1,267.5%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.1%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

PROF balance sheet trends, 2016–2025

Profound Medical Corp. balance sheet trends
MetricTrendThenLatestChange
Total assets$17.6M2016$192.9M2025+30.5%/yr
Total liabilities$6.6M2016$102.0M2025+35.6%/yr
Shareholders’ equity$11.0M2016$91.0M2025+26.4%/yr
Cash & short-term investments$15.5M2016$81.8M2025+20.3%/yr
Total debt$5.9M2016$6.5M2025+1.0%/yr
Net cash (debt)$9.6M2016$75.3M2025+$65.7M
Working capital$13.0M2016$95.9M2025+$82.9M
Book value per share$1.952018$3.012025+6.4%/yr
Debt / equity0.5320160.072025−0.46
Shares outstanding10.0M201830.2M2025+17.1%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

PROF assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

PROF liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

PROF debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

PROF balance sheet

Profound Medical Corp. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$81.8M$54.9M$26.2M$46.5M$67.1M$83.9M$14.7M$22.5M$8.8M$15.5M
Cash & equivalents$81.8M$54.9M$26.2M$46.5M$67.1M$83.9M$14.7M$22.5M$8.8M$15.5M
Short-term investments——−$134,114——————$0
Receivables$9.9M$7.0M$7.3M$6.3M$1.4M$7.4M$3.3M$2.3M$3.6M$394,565
Inventory$11.3M$5.8M$7.0M$7.9M$7.4M$5.3M$3.6M$2.7M$1.1M$310,113
Other current assets$1.3M$1.3M$1.4M$1.2M$1.1M$1.1M$1.0M$319,282$458,074$518,496
Total current assets$104.2M$69.1M$41.9M$62.0M$77.0M$97.7M$22.7M$27.8M$14.0M$16.7M
Property, plant & equipment (net)$225,000$821,010$1.6M$1.7M$1.9M$2.3M$2.2M$886,439$1.4M$709,046
Goodwill & intangible assets$138,000$261,000$490,000$680,000$4.1M$4.6M$5.0M$5.4M$6.8M$195,435
Long-term investments$0$0$0$0$0$0$0$0$0$0
Other non-current assets$88.4M$86,990$0$0$3.6M$0$1$2$2$0
Total assets$192.9M$70.2M$44.0M$64.4M$86.7M$104.6M$29.9M$34.2M$22.2M$17.6M
Liabilities
Accounts payable$2.1M$1.3M$865,000$2.0M$3.2M$3.4M$3.0M$2.9M$4.0M$1.3M
Short-term debt$291,731$2.0M$2.4M$762,000$249,661$312,000$4.1M$983,519$3.7M$2.1M
Deferred revenue—$419,000$721,000$471,000$476,354$358,000$501,246$229,479$191,901$192,911
Total current liabilities$8.3M$6.6M$6.4M$4.2M$4.1M$4.8M$8.2M$5.8M$8.5M$3.7M
Long-term debt$4.5M$2.9M$5.0M$6.7M$0$0$8.8M$10.6M$443,880$3.8M
Lease obligations$213,000$460,000$837,000$1.1M$1.4M$1.7M$2.4M———
Other long-term liabilities$89.1M$323,000$1.4M$1.6M$2.0M$2.4M$0$0$2.0M$0
Total liabilities$102.0M$9.8M$12.7M$12.4M$6.1M$7.3M$15.6M$14.6M$10.9M$6.6M
Shareholders' equity
Common stock & paid-in capital$443.5M$281.6M$222.2M$205.8M$219.3M$211.5M$99.7M$88.8M$78.2M$62.0M
Retained earnings (deficit)−$394.1M−$245.2M−$217.4M−$189.4M−$160.5M−$130.0M−$100.3M−$81.5M−$71.8M−$53.2M
Accumulated other comprehensive income$6.9M$2.7M$5.6M$16.8M$4.7M$4.6M−$89,712−$21,074−$46,067$8,419
Total shareholders' equity$91.0M$60.4M$31.2M$52.0M$80.5M$97.3M$14.3M$19.5M$11.2M$11.0M
Key figures
Total debt$6.5M$5.1M$7.9M$8.2M$1.4M$1.7M$13.0M$11.6M$4.2M$5.9M
Net cash (debt)$75.3M$49.8M$18.3M$38.3M$65.7M$82.2M$1.7M$10.9M$4.6M$9.6M
Working capital$95.9M$62.5M$35.5M$57.8M$72.9M$92.9M$14.5M$22.1M$5.5M$13.0M
Tangible book value$90.9M$60.2M$30.7M$51.3M$76.4M$92.8M$9.3M$14.1M$4.4M$10.8M
Book value per share$3.01$2.44$1.47$2.50$3.93$5.63$1.29$1.95——
Shares outstanding30.2M24.8M21.2M20.8M20.5M17.3M11.1M10.0M——
Current ratio12.5210.526.5814.8218.5620.322.774.811.644.54
Quick ratio11.029.445.2612.6316.5018.992.204.301.454.32
Debt / equity0.070.080.250.160.020.020.910.590.370.53
Equity / assets47.2%86.0%71.0%80.7%92.9%93.1%47.8%57.2%50.7%62.6%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 5, 2026); data from EODHD.

PROF financial position

At the end of fiscal 2025 (December 31, 2025), Profound Medical had total assets of $192.9 million (up 174.7% from a year earlier), total liabilities of $102.0 million and shareholders' equity of $91.0 million. It held $81.8 million in cash and short-term investments against $6.5 million of debt, a net cash position of $75.3 million. Its current ratio was 12.52. In the latest quarter (ended June 30, 2026) total assets were $62.4 million and equity $49.8 million.

Related: PROF income statement, PROF cash flow statement, PROF key metrics. See the PROF stock overview for the latest quote and news.

PROF balance sheet FAQ

What are Profound Medical's total assets?

Profound Medical reported total assets of $192.9 million at the end of fiscal 2025 (December 31, 2025), compared with $70.2 million a year earlier.

How much debt does Profound Medical have?

Profound Medical had $6.5 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.07.

How much cash does Profound Medical have?

Profound Medical held $81.8 million in cash and short-term investments at the end of fiscal 2025; with $6.5 million of debt that is net cash of $75.3 million.

What is Profound Medical's book value?

Profound Medical's shareholders' equity (book value) was $91.0 million at the end of fiscal 2025, or $3.01 per share.

What is Profound Medical's current ratio?

Profound Medical had current assets of $104.2 million and current liabilities of $8.3 million, a current ratio of 12.52 (it can cover its short-term obligations).

How much goodwill does Profound Medical have?

Profound Medical carried $0.1 million of goodwill and intangible assets, 0.1% of total assets, at the end of fiscal 2025.

Medical Devices: balance sheet